June 1, 2023
Francisco Orellana, a seasoned professional who has worked in the biotech sector for over twenty years, joined Exciva as Chief Financial Officer.
December 1, 2022
Nadine Knowles joined the Exciva team as Head of Clinical Operations. She has over thirty years of experience in operationalising clinical trials, with particular expertise in clinical studies focussing on agitation in Alzheimer's disease dementia, gained from her leadership roles at Avanir and Otsuka.
October 25, 2022
The US PTO granted a patent to Exciva for its invention of innovative composition of matter with various therapeutic uses in neuropsychiatry
October 11, 2022
Exciva successfully completed Phase I study of its proprietary EXV-802 combination of dextromethorphan and a 5-HT2A/2C receptor inverse agonist
July 1, 2022
Dr Jina Swartz joined Exciva as Chief Medical Officer bringing with her over twenty years of experience in Neuroscience global clinical development and translational medicine
October 26, 2021
Exciva raises €9 million in Series A round led by Andera Partners (full press release)